These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20502179)

  • 1. Adverse drug events in intensive care units: risk factors, impact, and the role of team care.
    Kane-Gill SL; Jacobi J; Rothschild JM
    Crit Care Med; 2010 Jun; 38(6 Suppl):S83-9. PubMed ID: 20502179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication administration errors in adult patients in the ICU.
    Calabrese AD; Erstad BL; Brandl K; Barletta JF; Kane SL; Sherman DS
    Intensive Care Med; 2001 Oct; 27(10):1592-8. PubMed ID: 11685299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit.
    Devlin JW; Mallow-Corbett S; Riker RR
    Crit Care Med; 2010 Jun; 38(6 Suppl):S231-43. PubMed ID: 20502176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors.
    White JR; Veltri MA; Fackler JC
    Pediatr Crit Care Med; 2005 Jan; 6(1):25-32. PubMed ID: 15636655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multidisciplinary approach to adverse drug events in pediatric trauma patients in an adult trauma center.
    Kalina M; Tinkoff G; Gleason W; Veneri P; Fulda G
    Pediatr Emerg Care; 2009 Jul; 25(7):444-6. PubMed ID: 19564808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
    Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
    Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations.
    Papadopoulos J; Smithburger PL
    Crit Care Med; 2010 Jun; 38(6 Suppl):S126-35. PubMed ID: 20502166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using technology to prevent adverse drug events in the intensive care unit.
    Hassan E; Badawi O; Weber RJ; Cohen H
    Crit Care Med; 2010 Jun; 38(6 Suppl):S97-S105. PubMed ID: 20502181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing implications for prevention of adverse drug events in the intensive care unit.
    George EL; Henneman EA; Tasota FJ
    Crit Care Med; 2010 Jun; 38(6 Suppl):S136-44. PubMed ID: 20502167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit.
    Buckley MS; Erstad BL; Kopp BJ; Theodorou AA; Priestley G
    Pediatr Crit Care Med; 2007 Mar; 8(2):145-52. PubMed ID: 17273111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardizing IV infusion medication concentrations to reduce variability in medication errors.
    Bullock J; Jordan D; Gawlinski A; Henneman EA
    Crit Care Nurs Clin North Am; 2006 Dec; 18(4):515-21. PubMed ID: 17118306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of adverse events in intensive care units.
    Kaushal R; Bates DW; Franz C; Soukup JR; Rothschild JM
    Crit Care Med; 2007 Nov; 35(11):2479-83. PubMed ID: 17828035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medication errors on intensive care units: don't underestimate the risks due to transcription].
    Benoit E; Eckert P; Beney J
    J Pharm Belg; 2012 Mar; (1):28-35. PubMed ID: 22536681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
    Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
    Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication reconciliation in a rural trauma population.
    Miller SL; Miller S; Balon J; Helling TS
    Ann Emerg Med; 2008 Nov; 52(5):483-91. PubMed ID: 18550221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission.
    Bokhari SW; Munir T; Memon S; Byrne JL; Russell NH; Beed M
    Ann Hematol; 2010 May; 89(5):505-12. PubMed ID: 19876629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of hospital stroke care.
    Holloway RG; Tuttle D; Baird T; Skelton WK
    Neurology; 2007 Feb; 68(8):550-5. PubMed ID: 17310024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.